SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000903423-18-000544
Filing Date
2018-10-10
Accepted
2018-10-10 17:08:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 urovant13d.htm SC 13D 204046
2 urovant13dex991.htm EX-99.1 5309
  Complete submission text file 0000903423-18-000544.txt   210825
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Subject) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-90671 | Film No.: 181116665
SIC: 2834 Pharmaceutical Preparations